BNP Paribas Financial Markets
TECX

BNP Paribas Financial Markets’s Tectonic Therapeutic TECX Stock Holding History

BNP Paribas Financial Markets’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87K Sell
2,816
-3
-0.1% -$74 ﹤0.01% 4443
2025
Q4 		$58.8K Buy
2,819
+397
+16% +$7.38K ﹤0.01% 4605
2025
Q3 		$38K Sell
2,422
-13,892
-85% -$287K ﹤0.01% 4706
2025
Q2 		$324K Buy
16,314
+13,718
+528% +$278K ﹤0.01% 3572
2025
Q1 		$46K Buy
2,596
+2,427
+1,436% +$79.1K ﹤0.01% 4319
2024
Q4 		$7.8K Buy
+169
New +$7.15K ﹤0.01% 4877
2024
Q3 		– Sell
-249
Closed -$4.1K – 4255
2024
Q2 		$4.1K Sell
249
-1
-0.4% -$16 ﹤0.01% 3778
2024
Q1 		$3.83K Hold
250
– – ﹤0.01% 3759
2023
Q4 		$4.07K Hold
250
– – ﹤0.01% 3767
2023
Q3 		$4.61K Hold
250
– – ﹤0.01% 3670
2023
Q2 		$2.85K Sell
250
-7
-3% -$79 ﹤0.01% 3708
2023
Q1 		$3.09K Sell
257
-125
-33% -$1.74K ﹤0.01% 3613
2022
Q4 		$3.27K Buy
382
+27
+8% +$238 ﹤0.01% 3697
2022
Q3 		$2.74K Sell
355
-2,321
-87% -$25.8K ﹤0.01% 4315
2022
Q2 		$29.5K Buy
2,676
+2,417
+933% +$28.5K ﹤0.01% 3656
2022
Q1 		$4.11K Sell
259
-587
-69% -$12.1K ﹤0.01% 3867
2021
Q4 		$39.1K Buy
846
+41
+5% +$2.35K ﹤0.01% 3781
2021
Q3 		$53.9K Buy
805
+426
+112% +$35K ﹤0.01% 3498
2021
Q2 		$40.4K Sell
379
-445
-54% -$52.8K ﹤0.01% 3342
2021
Q1 		$125K Buy
824
+476
+137% +$77.4K ﹤0.01% 3250
2020
Q4 		$58.2K Sell
348
-262
-43% -$46.6K ﹤0.01% 3484
2020
Q3 		$95.2K Buy
610
+396
+185% +$79.8K ﹤0.01% 3143
2020
Q2 		$44.8K Sell
214
-558
-72% -$115K ﹤0.01% 3080
2020
Q1 		$144K Sell
772
-5,904
-88% -$1.39M ﹤0.01% 3030
2019
Q4 		$1.61M Buy
6,676
+6,445
+2,790% +$1.24M ﹤0.01% 1783
2019
Q3 		$39.2K Buy
231
+111
+93% +$25.1K ﹤0.01% 3614
2019
Q2 		$23.5K Sell
120
-103
-46% -$22.2K ﹤0.01% 3844
2019
Q1 		$58.9K Buy
+223
New +$40.8K ﹤0.01% 3419

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BNP Paribas Financial Markets's TECX Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Tectonic Therapeutic (TECX) stake by 0.11% in Q1 2026, selling an estimated $74 and leaving 2,816 shares worth $87K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

BNP Paribas Financial Markets first reported a position in TECX in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.61M in Q4 2019. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • BNP Paribas Financial Markets held 2,816 shares of Tectonic Therapeutic worth $87K as of Q1 2026.
  • BNP Paribas Financial Markets sold 3 Tectonic Therapeutic shares in Q1 2026, an estimated $74.
  • Tectonic Therapeutic made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4443 holding.
  • BNP Paribas Financial Markets first reported a position in Tectonic Therapeutic in Q1 2019 and has held it in 28 quarters since.
  • BNP Paribas Financial Markets's Tectonic Therapeutic position peaked at $1.61M in Q4 2019.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.